MARKET DEFINITION

To treat liver cancer, radioembolization, a minimally invasive method, that combines embolization and radiation therapy. The tiny blood arteries feeding a tumor are loaded with radioactive yttrium Y-90-laden glass or resin beads. This stops the blood flow to the cancer cells and gives the tumor a high dosage of radiation while preserving healthy tissue. Patients with inoperable tumors may live longer and have a better quality of life thanks to the product & therapy.   Ionizing radiation is a specific kind of energy that is used in radiation treatment to destroy cancer cells and reduce tumor size. In contrast to external beam treatment (EBT), which involves inserting a radioactive substance into the body, radioembolization involves directing high-energy x-ray beams produced by a machine towards the tumor from outside the body.

 MARKET DYNAMICS  

The demand for the therapy is growing continuously owing to the rising prevalence of cancer. According to the CDC, U.S, approximately 25,000 men and 11,000 women are diagnosed with liver cancer each year in the US, and the disorder claims the lives of 19,000 men and 9,000 women. For many years, the number of Americans developing liver cancer increased. Liver cancer is common in the U.S as well as the African region. One of the factors, restricting the market growth is the high cost of the therapy.  On the other hand, the growing investments in the healthcare sector along with R&D activities carried out by many industry players and research institutes are projected to create lucrative opportunities in the near future.   

REPORT SCOPE

The report titled “Global Radioembolization Therapy Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Radioembolization Therapy market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Radioembolization Therapy market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Radioembolization Therapy Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION  

The Global Radioembolization Therapy Market is segmented based on procedure type, indication, end-user, and region. Based on Procedure Type, the market has been segmented into Transarterial Radioembolization (TERA), and Selective Internal Radiation Therapy (SIRT), whereas based on Indication, the market comprises Hepatocellular Carcinoma and Liver Cancer. Based on End-user, the market has been categorized into hospitals & Clinics, and Ambulatory Surgical Centers.

COMPETITION LANDSCAPE  

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Radioembolization Therapy market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Radioembolization Therapy market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Radioembolization Therapy market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Radioembolization Therapy industry in the past three years.

Key players in the Global Radioembolization Therapy Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• Terumo Corporation
• Boston Scientific Corporation
• BTG International Limited
• ABK Biomedical
• Nordion
• Other prominent players

COVID-19 IMPACT ANALYSIS ON GLOBAL RADIOEMBOLIZATION THERAPY MARKET  

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as the broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED  

1. What is the current size of the global Radioembolization Therapy market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Radioembolization Therapy market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:  

• The report offers comprehensive data on the Radioembolization Therapy market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents a precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis is included in the report which provides granular analysis of more than 20+ countries covered in the report's scope
• The study includes detailed profiles of major manufacturers to help our readers gain a holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical End-user
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Procedure Type Trends
3.2.2. Indication Trends
3.2.3. End-user Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Adaptive Learning Market
3.6. COVID-19 Impact Assessment in Adaptive Learning Market
3.6.1. Impact Assessment on Global Adaptive Learning Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4. Global Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
4.1. Global Adaptive Learning Market Share, By Procedure Type, 2017 - 2028 (USD Million)
4.1.1. Transarterial Radioembolization (TERA)
4.1.2. Selective Internal Radiation Therapy (SIRT)

Chapter 5. Global Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
5.1. Global Adaptive Learning Market Share, By Indication, 2017 - 2028 (USD Million)
5.1.1. Hepatocellular Carcinoma
5.1.2. Liver Cancer

Chapter 6. Global Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
6.1. Global Adaptive Learning Market Share, By End-user, 2017 - 2028 (USD Million)
6.1.1. Hospital & Clinics
6.1.2. Ambulatory Surgical Centers

Chapter 7. Global Adaptive Learning Market Overview, By Geography, 2017 - 2028 (USD Million)
7.1. Global Adaptive Learning Market Share, By Geography, 2017 - 2028 (USD Million)
7.1.1. Market Indication and Projections, by Countries, 2017 - 2028 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 8. North America Adaptive Learning Market Overview, By Countries, 2017 - 2028 (USD Million)
8.1. North America Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
8.1.1. Market Indication and projections, 2017 - 2028 (USD Million)
8.1.2. North America Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
8.1.3. North America Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
8.1.4. North America Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
8.2. North America Adaptive Learning Market Overview, By Countries, 2017 - 2028 (USD Million)
8.2.1. U.S. Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
8.2.1.1. U.S. Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
8.2.1.2. U.S. Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
8.2.1.3. U.S. Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
8.2.2. Canada Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
8.2.2.1. Canada Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
8.2.2.2. Canada Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
8.2.2.3. Canada Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
8.2.3. Mexico Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
8.2.3.1. Mexico Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
8.2.3.2. Mexico Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
8.2.3.3. Mexico Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 9. Europe Adaptive Learning Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. Europe Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market Indication and projections, 2017 - 2028 (USD Million)
9.1.2. Europe Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
9.1.3. Europe Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
9.1.4. Europe Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2. Europe Adaptive Learning Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. Germany Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. Germany Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
9.2.1.2. Germany Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.1.3. Germany Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2.2. France Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. France Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
9.2.2.2. France Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.2.3. France Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2.3. UK Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. UK Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
9.2.3.2. UK Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.3.3. UK Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2.4. Italy Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
9.2.4.1. Italy Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
9.2.4.2. Italy Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.4.3. Italy Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2.5. Spain Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
9.2.5.1. Spain Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
9.2.5.2. Spain Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.5.3. Spain Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2.6. NORDIC Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
9.2.6.1. NORDIC Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
9.2.6.2. NORDIC Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.6.3. NORDIC Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2.7. Russia and CIS Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
9.2.7.1. Russia and CIS Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
9.2.7.2. Russia and CIS Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.7.3. Russia and CIS Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
9.2.8. Rest of Europe Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
9.2.8.1. Rest of Europe Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
9.2.8.2. Rest of Europe Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.8.3. Rest of Europe Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 10. Asia Pacific Adaptive Learning Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Asia Pacific Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market Indication and projections, 2017 - 2028 (USD Million)
10.1.2. Asia Pacific Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
10.1.3. Asia Pacific Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
10.1.4. Asia Pacific Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2. Asia Pacific Adaptive Learning Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. India Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. India Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
10.2.1.2. India Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.1.3. India Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.2. China Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. China Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
10.2.2.2. China Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.2.3. China Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.3. Japan Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. Japan Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
10.2.3.2. Japan Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.3.3. Japan Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.4. ASEAN Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
10.2.4.1. ASEAN Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
10.2.4.2. ASEAN Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.4.3. ASEAN Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.5. South Korea Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
10.2.5.1. South Korea Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
10.2.5.2. South Korea Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.5.3. South Korea Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.6. Australia Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
10.2.6.1. Australia Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
10.2.6.2. Australia Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.6.3. Australia Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
10.2.7. Rest of Asia Pacific Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
10.2.7.1. Rest of Asia Pacific Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
10.2.7.2. Rest of Asia Pacific Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.7.3. Rest of Asia Pacific Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 11. South America Adaptive Learning Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. South America Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market Indication and projections, 2017 - 2028 (USD Million)
11.1.2. South America Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
11.1.3. South America Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
11.1.4. South America Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
11.2. South America Adaptive Learning Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. Brazil Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. Brazil Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
11.2.1.2. Brazil Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.1.3. Brazil Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
11.2.2. Argentina Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. Argentina Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
11.2.2.2. Argentina Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.2.3. Argentina Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
11.2.3. Rest of South America Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Rest of South America Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
11.2.3.2. Rest of South America Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.3.3. Rest of South America Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 12. Middle East & Africa Adaptive Learning Market Overview, By Countries, 2017 - 2028 (USD Million)
12.1. Middle East & Africa Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
12.1.1. Market Indication and projections, 2017 - 2028 (USD Million)
12.1.2. Middle East & Africa Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
12.1.3. Middle East & Africa Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
12.1.4. Middle East & Africa Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
12.2. Middle East & Africa Adaptive Learning Market Overview, By Countries, 2017 - 2028 (USD Million)
12.2.1. GCC Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
12.2.1.1. GCC Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
12.2.1.2. GCC Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.1.3. GCC Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
12.2.2. South Africa Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
12.2.2.1. South Africa Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
12.2.2.2. South Africa Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.2.3. South Africa Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)
12.2.3. Rest of Middle East & Africa Adaptive Learning Market Overview, 2017 - 2028 (USD Million)
12.2.3.1. Rest of Middle East & Africa Adaptive Learning Market Overview, By Procedure Type, 2017 - 2028 (USD Million)
12.2.3.2. Rest of Middle East & Africa Adaptive Learning Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.3.3. Rest of Middle East & Africa Adaptive Learning Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 13. Competitive Landscape
13.1. Competitive Environment, 2021
13.2. Strategic Framework
13.2.1. Partnership/Collaborations/Agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Product Development

Chapter 14. Key Vendor Analysis
14.1. Terumo Corporation
14.1.1. Business Overview
14.1.2. Product Benchmarking
14.1.3. Financial Data
14.1.4. Strategic Overview
14.1.5. Key Developments
14.1.6. SWOT Analysis
14.2. Boston Scientific Corporation
14.2.1. Business Overview
14.2.2. Product Benchmarking
14.2.3. Financial Data
14.2.4. Strategic Overview
14.2.5. Key Developments
14.2.6. SWOT Analysis
14.3. BTG International Limited
14.3.1. Business Overview
14.3.2. Product Benchmarking
14.3.3. Financial Data
14.3.4. Strategic Overview
14.3.5. Key Developments
14.3.6. SWOT Analysis
14.4. ABK Biomedical
14.4.1. Business Overview
14.4.2. Product Benchmarking
14.4.3. Financial Data
14.4.4. Strategic Overview
14.4.5. Key Developments
14.4.6. SWOT Analysis
14.5. Nordion
14.5.1. Business Overview
14.5.2. Product Benchmarking
14.5.3. Financial Data
14.5.4. Strategic Overview
14.5.5. Key Developments
14.5.6. SWOT Analysis
14.6. Other Prominent Players
14.6.1. Business Overview
14.6.2. Product Benchmarking
14.6.3. Financial Data
14.6.4. Strategic Overview
14.6.5. Key Developments
14.6.6. SWOT Analysis

Chapter 15. Future Outlook of the Market
Disclaimer